About Alievio
Alievio is a company based in Durham (United States) founded in 2010.. Alievio has raised $17.93 million across 11 funding rounds from investors including NIH, Charlotte Angel Fund and Triangle Angel Partners. Alievio offers products and services including Slot Games Platform and Login Service. Alievio operates in a competitive market with competitors including Glaukos, Myra Vision, Ivantis, Sensimed and Transcend Medical, among others.
- Headquarter Durham, United States
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.93 M (USD)
in 11 rounds
-
Latest Funding Round
$5.7 M (USD), Series A
Apr 11, 2018
-
Investors
NIH
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alievio
Alievio offers a comprehensive portfolio of products and services, including Slot Games Platform and Login Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for playing slot games with bonuses and secure access.
Secure login system for online slot game participation.
Funding Insights of Alievio
Alievio has successfully raised a total of $17.93M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $5.7 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series A — $5.7M
-
First Round
First Round
(01 Jan 2013)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2018 | Amount | Series A - Alievio | Valuation | VCapital , InFocus Capital Partners | |
| Apr, 2018 | Amount | Series A - Alievio | Valuation |
investors |
|
| Dec, 2017 | Amount | Series A - Alievio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alievio
Alievio has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, Charlotte Angel Fund and Triangle Angel Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investment opportunities are provided for accredited investors.
|
Founded Year | Domain | Location | |
|
Investment opportunities in ophthalmic innovations are managed by InFocus.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alievio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alievio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alievio Comparisons
Competitors of Alievio
Alievio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Glaukos, Myra Vision, Ivantis, Sensimed and Transcend Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of implants to treat glaucoma
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based devices for glaucoma treatment are developed.
|
|
| domain | founded_year | HQ Location |
Implantable device to relieve intraocular pressure in open angle glaucoma
|
|
| domain | founded_year | HQ Location |
A contact lens-based platform for glaucoma monitoring is offered.
|
|
| domain | founded_year | HQ Location |
Minimally invasive glaucoma stents are developed to enhance aqueous outflow.
|
|
| domain | founded_year | HQ Location |
Glaucoma is treated via the implantable MicroShunt device in ophthalmology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alievio
Frequently Asked Questions about Alievio
When was Alievio founded?
Alievio was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is Alievio located?
Alievio is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Who is the current CEO of Alievio?
Ray Krauss is the current CEO of Alievio.
Is Alievio a funded company?
Alievio is a funded company, having raised a total of $17.93M across 11 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Jan 01, 2013.
What does Alievio do?
Alevio has developed a device for treating glaucoma to target intraocular pressure (IOP). The company has developed a small noninvasive device used to remove the intraocular pressure by draining the aqueous humor and enables the physicians to maintain the IOP by adjusting the pressure. The company claims that the outlet tube is as soft as a contact lens.
Who are the top competitors of Alievio?
Alievio's top competitors include Glaukos, Myra Vision and Avisi Technologies.
What products or services does Alievio offer?
Alievio offers Slot Games Platform and Login Service.
Who are Alievio's investors?
Alievio has 8 investors. Key investors include NIH, Charlotte Angel Fund, Triangle Angel Partners, VCapital, and InFocus Capital Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.